Pure Global

Creatinine Quantitative Testing Drug - Vietnam Registration 240000442/PCBB-HCM

Access comprehensive regulatory information for Creatinine Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi B medical device is registered under number 240000442/PCBB-HCM and manufactured by Roche Diagnostics (Suzhou) Ltd.. The authorized representative in Vietnam is Cร”NG TY TNHH ROCHE VIแป†T NAM.

This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including Abbott Ireland Diagnostics Division, Ortho-Clinical Diagnostics Inc., and 4 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
3 Competitors
4 Recent Registrations
240000442/PCBB-HCM
Registration Details
Vietnam MOH Registration: 240000442/PCBB-HCM
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Creatinine Quantitative Testing Drug
VN: Thuแป‘c thแปญ xรฉt nghiแป‡m ฤ‘แป‹nh lฦฐแปฃng creatinine
Risk Class TTBYT Loแบกi B

Registration Details

240000442/PCBB-HCM

000.00.19.H29-240228-0028

CREP2

05168589214

Company Information

Technical Details

In vitro testing used to quantify creatinine in human serum, plasma, and urine on various Roche/Hitachi cobas systems.

Dates and Status

Mar 04, 2024

Companies Making Similar Products
Companies providing products similar to "Creatinine Quantitative Testing Drug"